Amanote Research
Register
Sign In
P2.15-24 Comparison of Pemetrexed Administered Q 3 Weeks vs Q 4 Weeks as Maintenance Therapy in NSCLC: Analysis of Real World Data From a Single Institution
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1466
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
G. Dy
S. Reddy
K. Wang
M. Faber
A. Meagher
H. Chen
G. Dy
Publisher
Elsevier BV
Related search
Real World Data and the Art of Maintenance Therapy
British Journal of Haematology
Hematology
Bortezomib Administered Pre-Auto-SCT and as Maintenance Therapy Post Transplant for Multiple Myeloma: A Single Institution Phase II Study
Bone Marrow Transplantation
Transplantation
Hematology
Two Weeks as a Chemist
Open Schools Journal for Open Science
Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
Oncologist
Cancer Research
Medicine
Oncology
Prognostic Value of a Single Exercise Test 3 Weeks After Uncomplicated Myocardial Infarction
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Development of Pre-Eclampsia Within 4 Weeks of sFlt-1/PlGF Ratio > 38: Comparison of Performance at 31-34vs35-37 Weeks' Gestation
Ultrasound in Obstetrics and Gynecology
Nuclear Medicine
Radiology
Ultrasound Technology
Gynecology
Reproductive Medicine
Radiological
Imaging
Obstetrics
Medicine
Golimumab Administered Subcutaneously Every 4 Weeks in Ankylosing Spondylitis: 104-Week Results of the GO-RAISE Study
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Pentaquark States With the $$QQQq\bar{q}$$ Q Q Q Q Q ¯ Configuration in a Simple Model
European Physical Journal C
Engineering
Astronomy
Physics
The Cost-Effectiveness of a NSCLC Patient Assistance Program for Pemetrexed Maintenance Therapy in People's Republic of China
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
